Nanotargeted agents: an emerging therapeutic strategy for breast cancer

Breast cancer is the most common female cancer worldwide and represents 12% of all cancer cases. Improvements in survival rates are largely attributed to improved screening and diagnosis. Conventional chemotherapy remains an important treatment option but it is beset with poor cell selectivity, seri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nanomedicine (London, England) England), 2019-07, Vol.14 (13), p.1771-1786
Hauptverfasser:	Du, Manling, Ouyang, Yong, Meng, Fansu, Ma, Qianqian, Liu, Hui, Zhuang, Yong, Pang, Mujuan, Cai, Tiange, Cai, Yu
Format:	Artikel
Sprache:	eng
Schlagworte:	Acids active targeting Bioavailability Biocompatibility Biomedical materials Breast cancer Cancer therapies Chemotherapy Drug delivery systems Drugs Immunotherapy Industrial production Lipids nano-targeted agents Nanoemulsions Nanoparticles Nanotechnology Particle size passive targeting physical and chemical targeting Polyethylene glycol Polymerization Polymers Radiation therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!